Thousand Oaks Biopharmaceuticals
PrivateLast Round
Series D
Dec 28, 2021
Est. Valuation
$1.33B
Total Funding Raised
$405.9M
Company Overview
Thousand Oaks Biopharmaceuticals operates in Healthcare & Life Sciences and is based in Nantong. Its latest recorded funding round was a Series D round in December 2021.
Thousand Oaks Biopharmaceuticals is a biotechnology company that offers contract development and manufacturing organization (CDMO) services, enabling partners to provide accessible and affordable biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thousand Oaks Biopharmaceuticals Comparables
Compare Thousand Oaks Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WuXi Biologics | 87% | |
| Chime Biologics | 86% | |
| MabPlex | 85% |
For institutional investors. Book with your work email.
Thousand Oaks Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 28, 2021 | ||||
| Series C | Mar 10, 2021 | ||||
| Series B | Jul 23, 2020 | ||||
| Series A | Jan 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Thousand Oaks Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series C |
| New Alliance Capital | Series A |
| CDH Investments | Series C |
| CCIC Capital | Series C |
| 中信金石投资有限公司 | Series C, Series D, Series B |
| CDH Baifu | Series D |
| Hillhouse Investment | Series D, Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2021
$61M round led by China Reform Fund Management and Hillhouse Investment.
For institutional investors. Book with your work email.
Thousand Oaks Biopharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Thousand Oaks Biopharmaceuticals's valuation, stock price, and market status.
Is Thousand Oaks Biopharmaceuticals a public or private company?
Thousand Oaks Biopharmaceuticals is a private company.
What is the current stock price of Thousand Oaks Biopharmaceuticals?
Thousand Oaks Biopharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Thousand Oaks Biopharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Thousand Oaks Biopharmaceuticals worth (valuation)?
Thousand Oaks Biopharmaceuticals's valuation is estimated at $1.3B based on funding round data.
Can I buy Thousand Oaks Biopharmaceuticals stock?
Thousand Oaks Biopharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Thousand Oaks Biopharmaceuticals's last funding round?
Thousand Oaks Biopharmaceuticals's most recent funding round was Series D on December 28, 2021.
Who are the main investors in Thousand Oaks Biopharmaceuticals?
Key investors in Thousand Oaks Biopharmaceuticals include New Alliance Capital, 中信金石投资有限公司, CDH Baifu, Hillhouse Investment, China Reform Fund Management Co.,Ltd.
Will Thousand Oaks Biopharmaceuticals IPO soon?
No public IPO plans have been announced for Thousand Oaks Biopharmaceuticals.
How can I track Thousand Oaks Biopharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Thousand Oaks Biopharmaceuticals's shares on secondary markets.